These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31958577)

  • 21. Clinical and Immunological Defects and Outcomes in Patients with Chromosome 22q11.2 Deletion Syndrome.
    Yu HH; Chien YH; Lu MY; Hu YC; Lee JH; Wang LC; Lin YT; Yang YH; Chiang BL
    J Clin Immunol; 2022 Nov; 42(8):1721-1729. PubMed ID: 35925483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-Wide Association Study to Find Modifiers for Tetralogy of Fallot in the 22q11.2 Deletion Syndrome Identifies Variants in the
    Guo T; Repetto GM; McDonald McGinn DM; Chung JH; Nomaru H; Campbell CL; Blonska A; Bassett AS; Chow EWC; Mlynarski EE; Swillen A; Vermeesch J; Devriendt K; Gothelf D; Carmel M; Michaelovsky E; Schneider M; Eliez S; Antonarakis SE; Coleman K; Tomita-Mitchell A; Mitchell ME; Digilio MC; Dallapiccola B; Marino B; Philip N; Busa T; Kushan-Wells L; Bearden CE; Piotrowicz M; Hawuła W; Roberts AE; Tassone F; Simon TJ; van Duin EDA; van Amelsvoort TA; Kates WR; Zackai E; Johnston HR; Cutler DJ; Agopian AJ; Goldmuntz E; Mitchell LE; Wang T; Emanuel BS; Morrow BE;
    Circ Cardiovasc Genet; 2017 Oct; 10(5):e001690. PubMed ID: 29025761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic heterogeneity in 22q11.2 deletion syndrome: Copy Number Variants as genetic modifiers for congenital heart disease in a Brazilian cohort.
    Zamariolli M; Dantas AG; Nunes N; Moysés-Oliveira M; Sgardioli IC; Soares DCQ; Gil-Da-Silva-Lopes VL; Kim CA; Melaragno MI
    Am J Med Genet A; 2023 May; 191(5):1273-1281. PubMed ID: 36751694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthopaedic manifestations within the 22q11.2 Deletion syndrome: A systematic review.
    Homans JF; Tromp IN; Colo D; Schlösser TPC; Kruyt MC; Deeney VFX; Crowley TB; McDonald-McGinn DM; Castelein RM
    Am J Med Genet A; 2018 Oct; 176(10):2104-2120. PubMed ID: 29159873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Autoimmune Thyroid Disease in a Cohort of 73 Paediatric Patients Affected by 22q11.2 Deletion Syndrome: Longitudinal Single-Centre Study.
    Ricci S; Sarli WM; Lodi L; Canessa C; Lippi F; Azzari C; Stagi S
    Genes (Basel); 2022 Aug; 13(9):. PubMed ID: 36140720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [22q11.2 microdeletion syndrome: Analysis of the care pathway before the genetic diagnosis].
    Ingrao T; Lambert L; Valduga M; Bosser G; Albuisson E; Leheup B
    Arch Pediatr; 2017 Nov; 24(11):1067-1075. PubMed ID: 28967605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in speech and language abilities between children with 22q11.2 deletion syndrome and children with phenotypic features of 22q11.2 deletion syndrome but without microdeletion.
    Rakonjac M; Cuturilo G; Stevanovic M; Jelicic L; Subotic M; Jovanovic I; Drakulic D
    Res Dev Disabil; 2016 Aug; 55():322-9. PubMed ID: 27235769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 22q11.2 Deletion Syndrome in Taiwan: Clinical Presentation and Immune System Status of Patients.
    Lee CL; Lin SM; Chen MR; Chuang CK; Chiu HC; Tu YR; Lo YT; Chang YH; Lin HY; Lin SP
    Int J Med Sci; 2023; 20(11):1377-1385. PubMed ID: 37790845
    [No Abstract]   [Full Text] [Related]  

  • 29. Fetal growth and gestational factors as predictors of schizophrenia in 22q11.2 deletion syndrome.
    Van L; Butcher NJ; Costain G; Ogura L; Chow EW; Bassett AS
    Genet Med; 2016 Apr; 18(4):350-5. PubMed ID: 26087175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prenatal cardiac findings and 22q11.2 deletion syndrome: Fetal detection and evaluation.
    Goldmuntz E; Bassett AS; Boot E; Marino B; Moldenhauer JS; Óskarsdóttir S; Putotto C; Rychik J; Schindewolf E; McDonald-McGinn DM; Blagowidow N
    Prenat Diagn; 2024 Jun; 44(6-7):804-814. PubMed ID: 38593251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of potential modifiers of the cardiac phenotype in the 22q11.2 deletion syndrome.
    Goldmuntz E; Driscoll DA; Emanuel BS; McDonald-McGinn D; Mei M; Zackai E; Mitchell LE
    Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):125-9. PubMed ID: 18770859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening.
    Wenger TL; Miller JS; DePolo LM; de Marchena AB; Clements CC; Emanuel BS; Zackai EH; McDonald-McGinn DM; Schultz RT
    Mol Autism; 2016; 7():27. PubMed ID: 27158440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of 22q11.2DS Using Multiplex Ligation-Dependent Probe Amplification as an Alternative Diagnostic Method.
    Maran S; Faten SA; Lim SE; Lai KS; Ibrahim WPW; Ankathil R; Gan SH; Tan HL
    Biomed Res Int; 2020; 2020():6945730. PubMed ID: 33062692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic characterisation of 22q11.2 variations and prevalence in patients with congenital heart disease.
    Hou HT; Chen HX; Wang XL; Yuan C; Yang Q; Liu ZG; He GW
    Arch Dis Child; 2020 Apr; 105(4):367-374. PubMed ID: 31666243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity in adults with 22q11.2 deletion syndrome.
    Voll SL; Boot E; Butcher NJ; Cooper S; Heung T; Chow EW; Silversides CK; Bassett AS
    Genet Med; 2017 Feb; 19(2):204-208. PubMed ID: 27537705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac function in adolescents and young adults with 22q11.2 deletion syndrome without congenital heart disease.
    Putotto C; Unolt M; Lambiase C; Marchetti F; Anaclerio S; Favoriti A; Tancredi G; Mastromoro G; Pugnaloni F; Liberati N; De Luca E; Tarani L; De Canditiis D; Caputo V; Bernardini L; Digilio MC; Marino B; Versacci P
    Eur J Med Genet; 2023 Jan; 66(1):104651. PubMed ID: 36404488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of 22q11.2 Deletion Syndrome via Newborn Screening for Severe Combined Immunodeficiency.
    Barry JC; Crowley TB; Jyonouchi S; Heimall J; Zackai EH; Sullivan KE; McDonald-McGinn DM
    J Clin Immunol; 2017 Jul; 37(5):476-485. PubMed ID: 28540525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of fatigue in adults with a 22q11.2 deletion syndrome.
    Vergaelen E; Claes S; Kempke S; Swillen A
    Am J Med Genet A; 2017 Apr; 173(4):858-867. PubMed ID: 28190295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex congenital heart disease in unaffected relatives of adults with 22q11.2 deletion syndrome.
    Swaby JA; Silversides CK; Bekeschus SC; Piran S; Oechslin EN; Chow EW; Bassett AS
    Am J Cardiol; 2011 Feb; 107(3):466-71. PubMed ID: 21257016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.